BackLipella Pharmaceuticals Overview

Lipella Pharmaceuticals Operating Income

Operating Income for LIPO.

Quarterly Operating Income

$-1274272000.00
↓ 12.69% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$-2604900867.00
↑ 7.93% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin